Table 2.
Demographic, clinical, and laboratory characteristics for the sample subjects. Patients were included within one month after diagnosis of Lyme neuroborreliosis (35 women and 34 men)
| Characteristic | Mean (standard deviation, range) or percentage (proportion) |
|---|---|
| Age (years) | 57.6 (13.5, 21–82) |
| Duration of neurological symptoms (days) | 28 (33, 1–180) |
| Tick-bite within last six months | 58.7% (37/63) |
| Erythema migrans within last six months | 24.6% (16/65) |
| Eye movement palsy | 1.4% (1/69) |
| Facial palsy | 53.6% (37/69) |
| Facial sensory disturbance | 11.6% (8/69) |
| Reduced hearing | 0 |
| CSFa cell count (cells/mm3) | 188 (173, 7–752) |
| CSFa protein level (g/l) | 1.4 (0.8, 0.3–3.9) |
| Positive Bbb antibody index | 80.6% (54/67c) |
aCSF cerebrospinal fluid
bBb Borrelia Burgdorferi
cTwo patients missed Bb antibody index due to blood contamination, both had positive Bb IgG in the cerebrospinal fluid and tick bite in the last six months. The subjects with negative index had duration of symptoms 15 (SD 14) days, and five had tick bite and two erythema migrans in the last 6 months